xing liu, Ph.D.

Duke Clinical Pharmacometrics Center, Duke Clinical Research Institute (DCRI)

Disclosure(s): No financial relationships to disclose

Poster(s):

• 232 - Population Pharmacokinetics (PopPK) of Ceftazidime-Avibactam (CZA) in Combination with Aztreonam (ATM) in a Phase I, Open-Label Study in Healthy Adult Subjects (COMBINE)
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET